Molkentin JD - Search Results

1

Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure.

Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, Grazette L, Michael A, Hajjar R, Force T, Molkentin JD. Haq S, et al. Among authors: molkentin jd. Circulation. 2001 Feb 6;103(5):670-7. doi: 10.1161/01.cir.103.5.670. Circulation. 2001. PMID: 11156878

2

Prevention of cardiac hypertrophy in mice by calcineurin inhibition.

Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Sussman MA, et al. Among authors: molkentin jd. Science. 1998 Sep 11;281(5383):1690-3. doi: 10.1126/science.281.5383.1690. Science. 1998. PMID: 9733519

3

Calcineurin and human heart failure.

Lim HW, Molkentin JD. Lim HW, et al. Among authors: molkentin jd. Nat Med. 1999 Mar;5(3):246-7. doi: 10.1038/6430. Nat Med. 1999. PMID: 10086361 No abstract available.

4

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Taigen T, De Windt LJ, Lim HW, Molkentin JD. Taigen T, et al. Among authors: molkentin jd. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1196-201. doi: 10.1073/pnas.97.3.1196. Proc Natl Acad Sci U S A. 2000. PMID: 10655507 Free PMC article.

5

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW 2nd, Kitsis RN, Molkentin JD. De Windt LJ, et al. Among authors: molkentin jd. Circ Res. 2000 Feb 18;86(3):255-63. doi: 10.1161/01.res.86.3.255. Circ Res. 2000. PMID: 10679475

6

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Lim HW, et al. Among authors: molkentin jd. J Mol Cell Cardiol. 2000 Apr;32(4):697-709. doi: 10.1006/jmcc.2000.1113. J Mol Cell Cardiol. 2000. PMID: 10756124

7

Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.

De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. De Windt LJ, et al. Among authors: molkentin jd. J Biol Chem. 2000 May 5;275(18):13571-9. doi: 10.1074/jbc.275.18.13571. J Biol Chem. 2000. PMID: 10788473 Free article.

8

Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Lim HW, et al. Among authors: molkentin jd. Circulation. 2000 May 23;101(20):2431-7. doi: 10.1161/01.cir.101.20.2431. Circulation. 2000. PMID: 10821822

9

Abnormalities of the genitourinary tract in female mice lacking GATA5.

Molkentin JD, Tymitz KM, Richardson JA, Olson EN. Molkentin JD, et al. Mol Cell Biol. 2000 Jul;20(14):5256-60. doi: 10.1128/MCB.20.14.5256-5260.2000. Mol Cell Biol. 2000. PMID: 10866681 Free PMC article.

10

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy.

Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T. Haq S, et al. Among authors: molkentin jd. J Cell Biol. 2000 Oct 2;151(1):117-30. doi: 10.1083/jcb.151.1.117. J Cell Biol. 2000. PMID: 11018058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters